Summary
For Year 2026-27, JB Chemicals & Pharmaceuticals reports the following shareholding: Total Promoters at 48.8%, Mutual Fund at 19%, Insurance at 1.33%, Foreign Institutional Investors at 16.33%, Domestic Institutional Investors at 1.05%, and Retail at 13.48%. This breakdown provides a quick snapshot of ownership distribution for JB Chemicals & Pharmaceuticals in 2026-27.
JB Chemicals & Pharmaceuticals FAQs
As of 04-2026, the promoter shareholding in JB Chemicals & Pharmaceuticals stands at 48.8% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of JB Chemicals & Pharmaceuticals is 16.33% and 1.05% respectively.
The retail shareholding of the JB Chemicals & Pharmaceuticals is 13.48%.
Changes in shareholding patterns of JB Chemicals & Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of JB Chemicals & Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
JB Chemicals & Pharmaceuticals Associated Pages
- JB Chemicals & Pharmaceuticals Share Price
- JB Chemicals & Pharmaceuticals Share Price chart
- JB Chemicals & Pharmaceuticals Fundamental Analysis
- JB Chemicals & Pharmaceuticals Technical Analysis
- JB Chemicals & Pharmaceuticals Peer Comparison
- JB Chemicals & Pharmaceuticals Share Price History
- JB Chemicals & Pharmaceuticals Dividend
- JB Chemicals & Pharmaceuticals Board of Directors
